Citation Impact
Citing Papers
Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care
2016
Interactions of Abiraterone, Eplerenone, and Prednisolone with Wild-type and Mutant Androgen Receptor: A Rationale for Increasing Abiraterone Exposure or Combining with MDV3100
2012
Nucleic acid detection with CRISPR-Cas13a/C2c2
2017 StandoutScience
Circulating Tumor DNA as a Liquid Biopsy for Cancer
2014
fastp: an ultra-fast all-in-one FASTQ preprocessor
2018 Standout
Detection of Clonal and Subclonal Copy-Number Variants in Cell-Free DNA from Patients with Breast Cancer Using a Massively Multiplexed PCR Methodology
2015
Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients
2016
Cell-free circulating tumor DNA in cancer
2016
Hepatocellular carcinoma
2016 Standout
Liquid biopsy: monitoring cancer-genetics in the blood
2013
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Prostate cancer
2015
Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes
2015
Comparison of KRAS mutation analysis of primary tumors and matched circulating cell-free DNA in plasmas of patients with colorectal cancer
2014
The Emerging Role of “Liquid Biopsies,” Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations
2017
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Should docetaxel be standard of care for patients with metastatic hormone-sensitive prostate cancer? Pro and contra
2015
Cancer-associated cachexia
2018 Standout
Multi‐marker analysis of circulating cell‐free DNA toward personalized medicine for colorectal cancer
2014
Highly Stereoselective Biocatalytic Synthesis of Key Cyclopropane Intermediate to Ticagrelor
2016 StandoutNobel
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer
2015 Nature
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
2014 Standout
AKT/PKB Signaling: Navigating the Network
2017 Standout
Clinical applications of the CellSearch platform in cancer patients
2018
AKT1 E17K mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detection
2016
Tumour heterogeneity and resistance to cancer therapies
2017 Standout
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
2017 Standout
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Pharmacotherapeutic strategies in the treatment of severe Alzheimer’s disease
2016
Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment
2017
Development of Therapeutic Combinations Targeting Major Cancer Signaling Pathways
2013
Synthetic approaches to the 2011 new drugs
2013
Combination therapy in combating cancer
2017 Standout
An update on the safety of current therapies for Alzheimer’s disease: focus on rivastigmine
2018
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
2014
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation
2016
Works of Amy Mulick being referenced
Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer
2013
Factors Associated with Greater Adherence to and Satisfaction with Transdermal Rivastigmine in Patients with Alzheimer's Disease and Their Caregivers
2015
Clinical and Biochemical Consequences of CYP17A1 Inhibition with Abiraterone Given with and without Exogenous Glucocorticoids in Castrate Men with Advanced Prostate Cancer
2011
Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance?
2012
Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers
2012
Unbiased and Automated Identification of a Circulating Tumour Cell Definition That Associates with Overall Survival
2011